KEMEXIVE Trademark

Trademark Overview

On Wednesday, September 27, 2017, a trademark application was filed for KEMEXIVE with the United States Patent and Trademark Office. The USPTO has given the KEMEXIVE trademark a serial number of 79222202. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, May 22, 2024. This trademark is owned by NOVARTIS AG. The KEMEXIVE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and treatment of cancer and tumors

General Information

Serial Number79222202
Word MarkKEMEXIVE
Filing DateWednesday, September 27, 2017
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, May 22, 2024
Registration Number5682562
Registration DateTuesday, February 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2018

Trademark Statements

Goods and Servicespharmaceutical preparations for the prevention and treatment of cancer and tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, May 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Thursday, November 30, 2017SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, December 4, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, December 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 12, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, January 3, 2018ASSIGNED TO EXAMINER
Friday, January 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2018NOTICE OF PUBLICATION
Tuesday, February 20, 2018PUBLISHED FOR OPPOSITION
Thursday, March 22, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 21, 2018OPPOSITION NOTICE (IB REFUSAL) CREATED
Tuesday, August 21, 2018OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Wednesday, August 29, 2018OPPOSITION INSTITUTED NO. 999999
Friday, September 7, 2018REFUSAL PROCESSED BY IB
Thursday, January 17, 2019OPPOSITION TERMINATED NO. 999999
Thursday, January 17, 2019OPPOSITION DISMISSED NO. 999999
Thursday, January 17, 2019TTAB RELEASE CASE TO TRADEMARKS
Friday, February 8, 2019LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, February 26, 2019REGISTERED-PRINCIPAL REGISTER
Friday, April 12, 2019LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sunday, May 26, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 21, 2019FINAL DISPOSITION PROCESSED
Friday, June 21, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 12, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 13, 2024DEATH OF INTERNATIONAL REGISTRATION

Related Keywords

kemexive cancer tumors treatment prevention preparations pharmaceutical